The EMT process includes adherence junction components (e.g., E-cadherin (ECAD)), matrix metalloproteinase (MMP) 7 and 9, tumor microenvironment components (e.g., cyclooxygenase-2 (COX-2)), and c-MET [21,22,23]. The gene discussed is PTGS2; the disease is neoplasm.